Healthy aging skin care brand OneSkin has secured a $7 million series A investment bringing its total funding to $20 million.
The oversubscribed round was led by Selva Ventures, a previous investor that the brand has been working with the last two years, with participation from Plus Capital; Unilever Ventures; Able Partners; Brazilian American model, designer and Matthew McConaughey’s wife Camila Alves McConaughey; tech entrepreneur Kevin Rose, and former investors SOSV and Meta Planet.
More from WWD
“We knew that we could utilize more resources to fuel the company’s growth, so we actually went around and talked to several investors, and luckily, we got several term sheets,” said cofounder, chief executive officer and Ph.D. Carolina Reis de Oliveira. “We saw a lot of interest in OneSkin and what we’re doing in our positioning and the traction that we got so far.”
OneSkin, founded by four scientists/Ph.D.s Reis de Oliveira, Alessandra Zonari, Mariana Boroni and Juliana Carvalho, is best known for its skin and body care infused with its signature OS-01 peptide, which the brand claims can reverse and slow skin aging by reducing senescent or “zombie” cells — the accumulation of senescent cells lead to skin aging and can negatively impact skin function. OneSkin has conducted clinical studies on the ingredient with third-party research organizations to back these claims. With its raise, the team plans to expand this level of innovation and research.
“One [goal] is to continue to foster innovation, so we know that OneSkin already has a very differentiated technology IP with our proprietary peptide,” Reis de Oliveira said. “We also know that science is evolving, and we are going to evolve together. We want to be the first ones to bring any advances in terms of addressing aging with the most effective peptides.”
According to Zonari, continued research could result in new ingredient findings and formula updates, though it’s early days.
“We continue being led by the research,” she said. “The commitment to continue researching novel ingredients that target or that are more efficient to target the root cause of skin aging is our mission.”
They are also planning to expand the team with this raise.
“The second piece [of the raise] is to build our team and bring seasoned professionals both for marketing, operations to continue to level up our growth [and] our performance,” Reis de Oliveira said.